Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biotech Bankruptcies: BIND and NephroGenex Weigh Options

May 02 2016

• By Lisa LaMotta

Related Content

NephroGenex soars on cardiac safety data

Jan 02 2015

In A BIND And Short On Cash

Apr 08 2016

Related Companies

BIND Therapeutics, Inc.

NephroGenex, Inc.

AstraZeneca PLC

Pfizer Inc.

Additional Topics

United States Business Strategies Cancer Renal

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window